Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole
- 23 August 1976
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 236 (8) , 946-948
- https://doi.org/10.1001/jama.236.8.946
Abstract
Twelve patients with severe renal failure and intercurrent urinary tract infections were treated with either ampicillin trihydrate, 500 mg 4 times a day, or trimethoprim-sulfamethoxazole, 2 tablets (80 mg trimethoprim, 400 mg sulfamethoxazole) twice a day. All patients achieved bacteriologic cure, including 6 with proved upper tract infection. Serum levels of all drugs were increased to values above those seen in normal subjects without adverse effects. Urine concentrations of trimethoprim, 28.6 .mu.g/ml, and ampicillin, 88.6 .mu.g/ml, were well above the minimum inhibitory concentrations of urinary pathogens. Urine sulfamethoxazole concentrations were less than 10 .mu.g/ml in 4 of the 6 patients treated, but this did not hamper bacteriologic success. Both drugs can apparently be used to treat urinary tract infections in patients with renal functional impairment.This publication has 4 references indexed in Scilit:
- Effect of Trimethoprim-Sulfamethoxazole on the Renal Excretion of Creatinine in ManJournal of Urology, 1975
- Trimethoprim-Sulfamethoxazole: Pharmacodynamic Effects of Urinary pH and Impaired Renal FunctionAnnals of Internal Medicine, 1973
- Oral Cephalexin and Ampicillin: Antimicrobial Activity, Recovery in Urine, and Persistence in Blood of Uremic PatientsAnnals of Internal Medicine, 1970
- TRIMETHOPRIM, A SULPHONAMIDE POTENTIATORBritish Journal of Pharmacology, 1968